[Potential antimicrobial drug interactions in clinical practice: consequences of polypharmacy and multidrug resistance].

Related Articles

[Potential antimicrobial drug interactions in clinical practice: consequences of polypharmacy and multidrug resistance].

Rev Esp Quimioter. 2015 Dec;28(6):282-8

Authors: Martínez-Múgica C

Abstract
BACKGROUND: Polypharmacy is a growing problem nowadays, which can increase the risk of potential drug interactions, and result in a loss of effectiveness. This is particularly relevant to the antiinfective therapy, especially when infection is produced by resistant bacteria, because therapeutic options are limited and interactions can cause treatment failure.
METHODS: All antimicrobial prescriptions were retrospectively reviewed during a week in the Pharmacy Department, in order to detect potential drug-interactions and analysing their clinical significance. A total of 314 antimicrobial prescriptions from 151 patients were checked.
RESULTS: There was at least one potential interaction detected in 40% of patients, being more frequent and severe in those infected with multidrug-resistant microorganisms. Drugs most commonly involved were quinolones, azoles, linezolid and vancomycin.
CONCLUSIONS: Potential drug interactions with antimicrobial agents are a frequent problem that can result in a loss of effectiveness. This is why they should be detected and avoided when possible, in order to optimize antimicrobial therapy, especially in case of multidrug resistant infections.

PMID: 26621171 [PubMed - in process]